The rat study is one I refer back to regularly to highlight the extraordinary DM priorities of PPS
"......Common findings between the two treatment approaches included reduced serum inflammatory markers, improved dentition and skull lengths, reduced tracheal deformities, and improved mobility."
- Forums
- ASX - By Stock
- What do they want?
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.76%
!
40.0¢

The rat study is one I refer back to regularly to highlight the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
40.0¢ |
Change
-0.020(4.76%) |
Mkt cap ! $156.9M |
Open | High | Low | Value | Volume |
42.0¢ | 42.3¢ | 39.5¢ | $314.2K | 774.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 56031 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 83007 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 56031 | 0.400 |
9 | 107889 | 0.395 |
11 | 59455 | 0.390 |
8 | 89345 | 0.385 |
8 | 59307 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 83007 | 6 |
0.410 | 40161 | 4 |
0.415 | 35378 | 7 |
0.420 | 58305 | 5 |
0.425 | 20000 | 1 |
Last trade - 11.51am 17/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Iggy Tan, Executive Chairman
Iggy Tan
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online